UK Chondroitin Sulfate Market Size & Outlook, 2022-2030
UK chondroitin sulfate market, 2017-2030 (US$M)
Related Markets
UK chondroitin sulfate market highlights
- The UK chondroitin sulfate market generated a revenue of USD 42.5 million in 2022 and is expected to reach USD 57.6 million by 2030.
- The UK market is expected to grow at a CAGR of 3.9% from 2023 to 2030.
- In terms of segment, bovine was the largest revenue generating source in 2022.
- Synthetic is the most lucrative source segment registering the fastest growth during the forecast period.
Chondroitin sulfate market data book summary
| Market revenue in 2022 | USD 42.5 million |
| Market revenue in 2030 | USD 57.6 million |
| Growth rate | 3.9% (CAGR from 2022 to 2030) |
| Largest segment | Bovine |
| Fastest growing segment | Synthetic |
| Historical data | 2017 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bovine, Swine, Poultry, Shark, Synthetic |
| Key market players worldwide | Merck KGaA, BRF SA ADR, Seikagaku, TSI Group, Bioiberica, Bio-gen Extracts |
Other key industry trends
- In terms of revenue, UK accounted for 3.5% of the global chondroitin sulfate market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany chondroitin sulfate market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 78.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Chondroitin Sulfate Market Scope
Chondroitin Sulfate Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK chondroitin sulfate market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chondroitin sulfate market will help companies and investors design strategic landscapes.
Bovine was the largest segment with a revenue share of 37.65% in 2022. Horizon Databook has segmented the UK chondroitin sulfate market based on bovine, swine, poultry, shark, synthetic covering the revenue growth of each sub-segment from 2017 to 2030.
In the UK, the homogeneity and purity of chondroitin sulfate derived from varied animal sources are strictly regulated by the government as the product is used in pharmaceutical sector for the treatment of osteoarthritis. In addition, any imported dietary supplements or food products of animal origin require legit certifications from the border inspection posts for free circulation in the country.
Dietary supplements containing chondroitin sulfate packaged for direct consumption are free from veterinary checks and can be imported without passing through the border inspection posts. Further, clinical studies have proved that chondroitin sulfate does not have any side effects on consumption. The aforementioned factors are anticipated to boost the demand for chondroitin sulfate in the country.
The UK is a prominent supplier of chondroitin sulfate as it meets USP and GMP standards. Nature’s Best is a prominent supplier of high-grade chondroitin sulfate in the country. Growing product consumption in nutraceutical and pharmaceutical sectors coupled with favorable government regulations for the usage of product in end use industries is anticipated to drive the chondroitin sulfate market in the country over the forecast period.
Reasons to subscribe to UK chondroitin sulfate market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK chondroitin sulfate market databook
-
Our clientele includes a mix of chondroitin sulfate market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK chondroitin sulfate market , including forecasts for subscribers. This country databook contains high-level insights into UK chondroitin sulfate market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK chondroitin sulfate market size, by source, 2017-2030 (US$M)
UK Chondroitin Sulfate Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
